Arbutus Biopharma Corporation (ABUS) at a glance

Arbutus Biopharma Corporation (ABUS) is a small-cap Healthcare company. It trades at $5.11, with a P/E of 5.1, a 84% profit margin and revenue growth of 10054.5%. It does not pay a dividend. Vestovix scores it 80/100 overall. Its strongest dimension is Value (99/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$5.11

Market cap

$841.5M

P/E ratio

5.1

Dividend yield

None

Beta

0.63

52-week range

$3.50 to $5.45